Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Samarth Kulkarni
24 Dec 2024
Chief Executive Officer
Exercised, kept
13,751
$16.21
$222.90K
Samarth Kulkarni
6 Dec 2022
Chief Executive Officer
Exercised, kept
58,233
$1.81
$105.40K
Samarth Kulkarni
20 Dec 2021
Chief Executive Officer
Exercised, kept
17,750
$1.81
$32.13K
James R. Kasinger
2 Dec 2021
General Counsel and Secretary
Exercised, kept
7,342
$13.62
$100.00K
Samarth Kulkarni
15 Oct 2021
Chief Executive Officer
Exercised, kept
33,000
$1.81
$59.73K
Samarth Kulkarni
29 Dec 2020
Chief Executive Officer
Exercised, kept
13,800
$1.81
$24.98K
James R. Kasinger
9 Dec 2020
General Counsel and Secretary
Exercised, kept
22,026
$13.62
$299.99K
Showing 250 of 546 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 196
Sales at will 315
Transactions with no price 0
Shares from compensation/vesting 20,354,169
Sales filed before the plan box existed 276
History held since 20 Oct 2016